Literature DB >> 3570904

Automatic digital contrast enhancement of radiotherapy films.

G W Sherouse, J Rosenman, H L McMurry, S M Pizer, E L Chaney.   

Abstract

The practice of radiotherapy involves the precise geometric localization of both anatomic and non-anatomic structures using radiographs which are typically of very low contrast. Portal and verification films suffer from poor contrast as a result of the dominance of Compton interactions at therapeutic energies, and implant localization films often are degraded by extreme patient thickness (lateral pelvis) or projection of bony structures (head and neck). Automatic contrast enhancement techniques developed and proven for optimization of the display of digitally produced images such as CT have been applied to radiotherapy films to improve contrast and augment readability. This approach has become viable only recently with the advent of high speed, high resolution film digitizers and laser cameras and the evolution of sufficiently powerful computer hardware.

Entities:  

Mesh:

Year:  1987        PMID: 3570904     DOI: 10.1016/0360-3016(87)90303-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  Digital contrast enhancement for online portal imaging.

Authors:  K W Leszczynski; S Shalev
Journal:  Med Biol Eng Comput       Date:  1989-09       Impact factor: 2.602

2.  [Monitor assessment of digitalized and post-processed portal films compared to conventional films presented on a light box].

Authors:  S Wachter; N Gerstner; A Colotto; A Battmann; A Gahleitner; U Haverkamp; R Pötter
Journal:  Strahlenther Onkol       Date:  1998-11       Impact factor: 3.621

3.  Enhancement of megavoltage electronic portal images for markerless tumor tracking.

Authors:  Kwang-Ho Cheong; Jai-Woong Yoon; Soah Park; Taejin Hwang; Sei-Kwon Kang; Taeryool Koo; Tae Jin Han; Haeyoung Kim; Me Yeon Lee; Kyoung Ju Kim; Hoonsik Bae
Journal:  J Appl Clin Med Phys       Date:  2018-07-09       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.